0000950123-22-010047.txt : 20221005 0000950123-22-010047.hdr.sgml : 20221005 20221005164121 ACCESSION NUMBER: 0000950123-22-010047 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221005 DATE AS OF CHANGE: 20221005 EFFECTIVENESS DATE: 20221005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC CENTRAL INDEX KEY: 0001831423 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20380 FILM NUMBER: 221296160 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001831423 XXXXXXXX 09-30-2022 09-30-2022 false Vida Ventures Advisors, LLC
40 Broad Street Suite 201 Boston MA 02109
13F HOLDINGS REPORT 028-20380 N
Jean-Philippe Kouakou-Zebouah Chief Financial Officer 857-254-9492 /s/ Jean-Philippe Kouakou-Zebouah Boston MA 10-05-2022 0 8 111423 false
INFORMATION TABLE 2 17412.xml INFORMATION TABLE FOR FORM 13F Allogene Therapeutics, Inc. Common Stock 019770106 19420 1798163 SH SOLE 1798163 0 0 Centessa Pharmaceuticals plc Ordinary Shares 152309100 15805 3931818 SH SOLE 3931818 0 0 Dyne Therapeutics, Inc. Common Stock 26818M108 28194 2220034 SH SOLE 2220034 0 0 Homology Medicines, Inc. Common Stock 438083107 1121 696289 SH SOLE 696289 0 0 Kinnate Biopharma, Inc. Common Stock 49705R105 26383 2207772 SH SOLE 2207772 0 0 Kronos Bio, Inc. Common Stock 50107A104 9264 2765314 SH SOLE 2765314 0 0 LianBio Ordinary Shares 53000N108 4564 2282084 SH SOLE 2282084 0 0 Praxis Precision Medicines, Inc. Common Stock 74006W108 6672 2939329 SH SOLE 2939329 0 0